Meggiato T, Calabrese F, De Cesare CM, et al. C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death[J]. Pancreas, 2003, 26(1): 65-70.
[2]
Roy S, Bayly CI, Gareau Y, et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide[J]. Proc Natl Acad Sci USA, 2001, 98(11): 6132-6137.
[3]
Epsztejn S, Kakhlon O, Glickstein H, et al. Fluorescence analysis of the labile iron pool of mammalian cells[J]. Anal Biochem, 1997, 248(1): 31-40.
[4]
Palozza P, Serini S, Torsello A, et al. Mechanism of activation of caspase cascade during beta-carotene-induced apoptosis in human tumor cells[J]. Nutr Cancer, 2003, 47(1): 76-87.
[5]
Keri G, Racz G, Magyar K, et al. Pro-apoptotic and anti-apoptotic molecules affecting pathways of signal transduction[J]. Ann NY Acad Sci, 2003, 1010(12): 109-112.
[6]
Roy S, Bayly CI, Gareau Y, et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide[J]. Proc Natl Acad Sci USA, 2001, 98(11): 6132-6137.
Fang D, Bao Y, Li X, Liu F. Effects of iron deprivation on multidrug resistance of leukemic K562 cells[J]. Chemotherapy, 2010, 56(1): 9-16.
[11]
Noulsri E, Richardson DR, Lerdwana S. et al. Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells[J]. Am J Hematol, 2009, 84(3): 170-176.
[12]
Mori S, Sawada T, Okada T, et al. Anti-proliferative effect of interferon-gamma is enhanced by iron chelation in colon cancer cell lines in vitro[J]. Hepatogastroenterology, 2008, 55(85): 1274-1279.
[13]
Kontoghiorghes GJ, Efstathiou A, Ioannou-Loucaides S, et al. Chelators controlling metal metabolism and toxicity pathways: applications in cancer prevention, diagnosis and treatment[J]. Hemoglobin, 2008, 32(1-2): 217-227.
Yang R, Muller C, Huynh V, et al. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins[J]. Mol Cell Biol, 1999, 19(3): 2400-2407.
